A Study of TAR-200 in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who Are Unfit for Radical Cystectomy
Clinical trial NCT03404791 · COMPLETED
Trial details
- NCT number
- NCT03404791
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-20
- Primary completion
- 2019-12-23
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.